SpringWorks Therapeutics stock surged over Monday after a report from Reuters that German medical tech giant Merck KGaA could be close to acquiring the company.

The Investment Committee debate the Calls of the Day in two biotech names.

Vamil Divan, Guggenheim Securities biopharmaceutical analyst, joins 'Power Lunch' to discuss Merck's troubles in China. ‘Stench’ of Nazi appeasement hangs over Donald Trump Ukraine peace talks ...

If Trump’s talks with Putin facilitate a pause in the fighting, Ukraine will decline in salience as a point of contention ...

For a small island of just over 5 million people on Europe's western edge, Ireland is playing an outsize role in the travel ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 36 tables and 60 figures, this 133-page report Asia Pacific Bioprocess Technology Market 2023-2033 by Product (Instruments, ...

Donald Trump paused the implementation of his proposed tariffs for a month in Mexico and Canada after conversations with ...

His clients have included the makers of the movie "American Made" and National Football League wide receiver Willie Gault, as well as corporations Merck and ... meeting on Ukraine without Ukraine ...

RBC Capital Markets analyst Bish Koziol made eight changes to his quantitatively driven top 40 list of stock picks. Maple Leaf Foods ( N/A , growth, value and predictability scores declined), Waste ...

Trump’s pardon came after Sutton and Zabavsky were unanimously found guilty by a federal grand jury in 2022 of conspiracy to obstruct and obstruction of justice over the incident, as well as ...

More news on Robert F Kennedy Jr: Trump’s nomination for the top US health official says he will keep his share of any windfall from litigation against pharmaceutical company Merck. 4.

Robert F Kennedy Jr, Trump’s pick for a top US health role, plans to keep his share of any windfall from a suit against Merck’s vaccine ... soon to end the war in Ukraine.